First description of CTX-M-3 extended-spectrum β-lactamase in an outbreak strain of Shiga toxin-producing Escherichia coli O103:H2

Int J Antimicrob Agents. 2016 Mar;47(3):244-5. doi: 10.1016/j.ijantimicag.2015.12.014. Epub 2016 Jan 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Disease Outbreaks
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology
  • Female
  • Humans
  • Microbial Sensitivity Tests
  • Republic of Korea / epidemiology
  • Shiga-Toxigenic Escherichia coli / drug effects*
  • Shiga-Toxigenic Escherichia coli / genetics*
  • Shiga-Toxigenic Escherichia coli / isolation & purification
  • beta-Lactam Resistance / genetics*
  • beta-Lactamases / genetics*

Substances

  • beta-lactamase CTX-M-3
  • beta-Lactamases